Intracranial infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. This study included neurosurgical patients with lumbar cistern drainage tubes following the operation who were diagnosed in the Neurosurgery Department of the Second Hospital of Hebei Medical University at the ages between 18 and 70. These patients received a norvancomycin treatment for intracranial infections. 2. The diagnostic criteria for the infections were described as follows: 1) a positive MRSA in the CSF cultures; 2) temperature 38 degree C, headache, vomit, and meningeal irritation signs such as nuchal rigidity, Kernigs sign, and Brudzinskis sign; 3) the following abnormalities in the CSF test: WBC count > 1000 x 10^6 cells/L, CSF glucose 500 mg/L.
Exclusion criteria
Exclusion criteria: The following patients were excluded from this study: 1. those who had undergone an antibiotic therapy against gram-positive bacteria, including MRSA during one week prior to the onset of study; 2. those with histories of dysfunctions in lung, heart, liver (alanine aminotransferase or aspartate aminotransferase > 40 U/L), kidney (endogenous creatinine clearance < 10 mL/min), or other organs; 3. those who were female patients at the perinatal period; 4. those with a record of NVCM or vancomycin allergy; 5. those who failed to sustain spontaneous breathing or were in an agonal condition, or in a deep coma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug concentration in cerebrospinal fluid;cure time;Pharmacokinetic data; | — |
Secondary
| Measure | Time frame |
|---|---|
| CSF WBC;CSF glucose;CSF protein;CSF chloride;adverse reaction;White blood cell count in blood; | — |
Countries
China
Contacts
The Second Hospital of Hebei Medical University